Search

130 Result(s)
Sort by

Respiratory

Respiratory

Human Pharma Clinical Pipeline Respiratory therapeutic area
Immunology

Immunology

Human Pharma Clinical Pipeline Immunology therapeutic area
Retinal Health

Retinal Health

Human Pharma Clinical Pipeline Retinal Health therapeutic area
Mental Health

Mental Health

Human Pharma Clinical Pipeline Mental Health therapeutic area
FDA-CRL-T1D

FDA-CRL-T1D

US FDA issues complete response letter for treatment of adults with type 1 diabetes
Vienna

Vienna

Vienna is a cornerstone within the company’s global R&D network, with a special focus on cancer research. On top of that, it is also a hub for biopharmaceutical development and production.
Our Vision

Our Vision

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye.
Immunology

Immunology

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in immunology.
Heidelberg Transforming Science Day 2025

Heidelberg Transforming Science Day 2025

The Heidelberg Transforming Science Day profiles what makes our innovation different including our ground-breaking research and our diverse pipeline.
Collaboration-with-OxfordBioTherapeutics

Collaboration-with-OxfordBioTherapeutics

Boehringer Ingelheim collaborates with Oxford BioTherapeutics to discover tumor targets to deliver first-in-class treatments for cancer patients.
Partnership-with-clicktherapeutics

Partnership-with-clicktherapeutics

Boehringer Ingelheim collaborates with Click Therapeutics on prescription-based digital therapeutic to potentially aid in the treatment of schizophrenia